
Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
This trial was looking at a drug called decitabine in combination with ECF chemotherapy for advanced stomach cancer.
Doctors often treat cancer of the stomach (gastric cancer) with chemotherapy and surgery. One of the most common types of chemotherapy for stomach cancer is a combination of drugs called ECF. This is epirubicin, cisplatin and fluorouracil (5FU).
In this trial, doctors wanted to see if another drug called decitabine made ECF work better. Decitabine works by changing the activity of some of the in the cancer cells. This may make the cells more sensitive to ECF. Doctors hoped that adding this new drug would make ECF more effective.
The aims of the trial were to find out
Despite attempting to contact the trial team, we have been unable to get any results for this trial.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Mark Middleton
Experimental Cancer Medicine Centre (ECMC)
MGI Pharma Inc
Freephone 0808 800 4040
Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.